Y-Intercept (HK)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.8M Buy
1,120,331
+670,060
+149% +$36.4M 0.95% 3
2026
Q1
$28.3M Buy
450,271
+387,819
+621% +$31M 0.54% 9
2025
Q4
$5.95M Buy
+62,452
New +$6.12M 0.13% 176
2023
Q2
Sell
-48,645
Closed -$2.43M 1291
2023
Q1
$2.43M Buy
48,645
+43,380
+824% +$2.04M 0.28% 60
2022
Q4
$244K Buy
+5,265
New +$228K 0.04% 746
2022
Q2
Sell
-23,254
Closed -$1.03M 878
2022
Q1
$1.03M Buy
+23,254
New +$1.01M 0.24% 110
2021
Q3
Sell
-14,634
Closed -$626K 660
2021
Q2
$626K Buy
14,634
+2,506
+21% +$105K 0.16% 209
2021
Q1
$473K Buy
+12,128
New +$459K 0.13% 269

Other funds holding BSX

Y-Intercept (HK)'s BSX Position: Q2 2026 in Review

Y-Intercept (HK) increased its Boston Scientific (BSX) stake by 149% in Q2 2026, buying an estimated $36.4M and bringing the position to 1,120,331 shares worth $47.8M. The position accounts for 0.95% of the portfolio, ranked #3.

Y-Intercept (HK) first reported a position in BSX in Q1 2021 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Y-Intercept (HK) held 1,120,331 shares of Boston Scientific worth $47.8M as of Q2 2026.
  • Y-Intercept (HK) bought 670,060 Boston Scientific shares in Q2 2026, an estimated $36.4M.
  • Boston Scientific made up 0.95% of Y-Intercept (HK)'s portfolio in Q2 2026, its #3 holding.
  • Y-Intercept (HK) first reported a position in Boston Scientific in Q1 2021 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.